Humanized anti-TNF-α monoclonal antibodies (anti-TNF-α mAB) such as infliximab are used in the treatment of rheumatic and autoimmune diseases, including rheumatoid arthritis or psoriasis as well as GI diseases such as CD and UC. This evidence concerns the gene TNF and autoimmune disease.